Showing results (11-20 of 1,096) with videos related to
Sort By:
Pageof 110
Eclinicalmedicine|October 17, 2022
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trialLinong Ji, Leili Gao, Hongwei Jiang, et al.Diabetes Research and Clinical Practice|November 24, 2023
Association between frequency of self-monitoring of blood glucose and glycemic control in patients with type 2 diabetesXiaoyan Sun, Xianghai Zhou, Shaobo Li, et al.Diabetes/Metabolism Research and Reviews|September 30, 2015
DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Xueyao Han, et al.Expert Opinion on Pharmacotherapy|November 2, 2017
Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.Journal of Diabetes|July 22, 2014
Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysisXiaoling Cai, Xueyao Han, Yingying Luo, et al.The International Journal of Lower Extremity Wounds|March 25, 2014
Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in ChinaAihong Wang, Zhangrong Xu, Yiming Mu, et al.Journal of Diabetes Research|April 16, 2014
P38 plays an important role in glucolipotoxicity-induced apoptosis in INS-1 cellsLingli Zhou, Xiaoling Cai, Xueyao Han, et al.Plos One|June 22, 2012
Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatmentXiaoling Cai, Xueyao Han, Yingying Luo, et al.Obesity (Silver Spring, Md.)|May 28, 2024
Characterization of tirzepatide-treated patients achieving different glycemic control levels in SURPASS-AP-ComboYuqian Bao, Lin Han, Liying Du, et al.Plos One|November 16, 2013
Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and CaucasianXiaoling Cai, Xueyao Han, Yingying Luo, et al.Pageof 110